(113 days)
Not Found
No
The summary describes a software system for processing and analyzing physiological data from an oximeter and other sensors to aid in detecting CSR and estimating AHI. It mentions "scoring analysis" and "processing raw signal data," but there is no mention of AI, ML, deep learning, or any related terms or concepts typically associated with these technologies. The description focuses on data management, display, and report generation based on acquired signals.
No
The device aids in detection and estimation of conditions rather than providing therapy. It is a diagnostic tool for physicians.
Yes
The device aids in the detection of Cheyne-Stokes Respiration (CSR) and estimates Apnea Hypopnea Index (AHI) to help identify Sleep Disordered Breathing (SDB), which are diagnostic functions.
Yes
The device description explicitly states it is a "computer program (software)" and its function is to process data acquired from an external oximeter device. It does not include any hardware components.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, tissue) to provide information for the diagnosis, treatment, or prevention of disease.
- Morpheus Ox Function: The Morpheus Ox System processes physiological data received from an oximeter device. It analyzes signals like saturation, heart rate, and other physiological parameters acquired externally from the patient via the oximeter. It does not involve the analysis of specimens taken from the body.
- Intended Use: The intended use is to aid in the detection of Cheyne-Stokes Respiration and estimate AHI based on physiological data, not on the analysis of biological samples.
Therefore, the Morpheus Ox System falls under the category of a medical device that analyzes physiological signals, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Morpheus Ox Automated Sleep Study Scoring and Data Management System is a computer program (software) intended for use as an aid in the detection of Chevne-Stokes Respiration (CSR), and to estimate Apnea Hypopnea Index (AHI), in a Cardiac patient population that is suspected of having Sleep Disordered Breathing (SDB). The Morpheus Ox System is intended to be used for analysis, display, redisplay (retrieve), reports generation and networking of physiological data received from an oximeter device. It does not perform automatic classification of respiratory events as central or obstructive. This system is to be used under the supervision of a physician.
Morpheus Ox displays heart rate, saturation and photoplethysmograph signals, acquired from an oximeter device. Morpheus Ox may also display signals including: EtCO2, Respiratory impedance, Plethysmograph Derived Respiratory (PDR) calculated signal, Activity, ECG, EEG, P flow, C flow, EMG, EOG, Snore, Leg movement, Abdomen, Thorax, EPAP, IPAP.
Product codes
MNR
Device Description
The Morpheus Ox Automated Sleep Study Scoring and Data Management System is a computer program (software) intended for use as an aid in the detection of Cheyne-Stokes Respiration (CSR), and to estimate Apnea Hypopnea Index (AHI), in a Cardiac patient population that is suspected of having Sleep Disordered Breathing (SDB).
The Morpheus Ox System is designed to process the raw signal data acquired by an oximeter device in standard medical download format, analyze them, obtain the study's analysis results, generate summary reports, and display the signals' data and reports on a personal computer, using a standard Internet Explorer Browser.
Signals from the oximeter device include the following:
- o Saturation
- o Photoplethysmograph signal
Scoring analysis and display includes:
- O Cheyne-Stokes Respiration (CSR)
- 0 Apnea/Hypopnea Index (AHI)
- o Display of acquired signals such as EtCO2, Respiratory impedance, Photoplethysmograph Derived Respiratory (PDR) calculated signal, ECG, EEG, P flow, T flow, C flow, EMG, EOG, Snore, Leg movement, Abdomen, Thorax, EPAP, IPAP, and Heart rate.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
This system is to be used under the supervision of a physician.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Software verification and validation testing was conducted to evaluate the performance of the Morpheus Ox System and to verify that it performs according to its specifications described in the Software Requirements Specifications (SRS). In addition, a clinical study was conducted to validate the accuracy of the Morpheus Ox System against both a gold-standard PSG and predicate device.
Key Metrics
Not Found
Predicate Device(s)
K070326, K070263, K071230, K060708
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 868.2375 Breathing frequency monitor.
(a)
Identification. A breathing (ventilatory) frequency monitor is a device intended to measure or monitor a patient's respiratory rate. The device may provide an audible or visible alarm when the respiratory rate, averaged over time, is outside operator settable alarm limits. This device does not include the apnea monitor classified in § 868.2377.(b)
Classification. Class II (performance standards).
0
510(k) SUMMARY
510(k) Number K_l |3 | 4
| 5.1 Applicant's Name: | WideMed LTD
10, Ha'sadnaot st.
Herzliya 46733, Israel
Tel: +972 9 951 4159
Fax: +972 9 951 4158 |
| ----------------------- | ------------------------------------------------------------------------------------------------------------- |
|---|
5.2 Contact Person: John Smith, M.D., J.D. Hogan Lovells US LLP Columbia Square 555 Thirteenth Street. NW Washington, DC 20004 T +1 202 637 5600 F +1 202 637 5910 www.hoganlovells.com
- 5.3 Date Prepared: May 4, 2011
| 5.4 Trade Name: | Morpheus Ox Automated Sleep Study
Scoring and Data Management System |
|--------------------------|-------------------------------------------------------------------------|
| 5.5 Classification Name: | Ventilatory Effort Recorder / Breathing
Frequency Monitor |
- 5.6 Medical Specialty: Anesthesiology
- 5.7 Product Code: Ventilatory Effort Recorder, MNR
- 5.8 Device Class: Class II
- રું. તે જે Regulation Number: 21 C.F.R. §868.2375
- 5.10 Panel: Anesthesiology
5.11 Predicate Devices:
- l . The Noga Automated Sleep Study Scoring and Data Management System (WideMed, Ltd.), cleared under K070326
-
- Apnealink (Resmed, Germany) cleared under K070263
-
- ARES (Advanced Brain Monitoring, Inc, USA) cleared under K071230
- Somnomedics SOMNOscreen (Somnomedics GMBH & Company KG.); 4. cleared under K060708
1
5.12 Performance Standards:
-
- IEC 60601-1-4 + A1, Medical electrical equipment Part 1: General requirements for safety 4. Collateral Standard: Programmable electrical medical systems, Edition 1.1, 2000-4
-
- ISO 14971-1, Application of risk management to medical devices, 2007.
5.13 Intended Use / Indication for Use:
The Morpheus Ox Automated Sleep Study Scoring and Data Management System is a computer program (software) intended for use as an aid in the detection of Chevne-Stokes Respiration (CSR), and to estimate Apnea Hypopnea Index (AHI), in a Cardiac patient population that is suspected of having Sleep Disordered Breathing (SDB). The Morpheus Ox System is intended to be used for analysis, display, redisplay (retrieve), reports generation and networking of physiological data received from an oximeter device. It does not perform automatic classification of respiratory events as central or obstructive. This system is to be used under the supervision of a physician.
Morpheus Ox displays heart rate, saturation and photoplethysmograph signals, acquired from an oximeter device. Morpheus Ox may also display signals including: EtCO2, Respiratory impedance, Plethysmograph Derived Respiratory (PDR) calculated signal, Activity, ECG, EEG, P flow, C flow, EMG, EOG, Snore, Leg movement, Abdomen, Thorax, EPAP, IPAP.
5.14 Device Description:
The Morpheus Ox Automated Sleep Study Scoring and Data Management System is a computer program (software) intended for use as an aid in the detection of Cheyne-Stokes Respiration (CSR), and to estimate Apnea Hypopnea Index (AHI), in a Cardiac patient population that is suspected of having Sleep Disordered Breathing (SDB).
The Morpheus Ox System is designed to process the raw signal data acquired by an oximeter device in standard medical download format, analyze them, obtain the study's analysis results, generate summary reports, and display the signals' data and reports on a personal computer, using a standard Internet Explorer Browser.
Signals from the oximeter device include the following:
- o Saturation
- o Photoplethysmograph signal
Scoring analysis and display includes:
- O Cheyne-Stokes Respiration (CSR)
- 0 Apnea/Hypopnea Index (AHI)
- o Display of acquired signals such as EtCO2, Respiratory impedance, Photoplethysmograph Derived Respiratory (PDR) calculated signal,
ﺗﻤﻤ
()
2
ECG, EEG, P flow, T flow, C flow, EMG, EOG, Snore, Leg movement, Abdomen, Thorax, EPAP, IPAP, and Heart rate.
5.15 Substantial Equivalence:
Intended Use
ో
Like the cleared predicate devices, the Morpheus Ox System is intended for use as an aid in diagnosing sleep related breathing disorders. Accordingly, the device meets its first requirement of substantial equivalence.
Additionally, the Morpheus Ox System is further indicated to aid in the detection of Cheyne-Stokes Respiration (CSR), and to estimate Apnea Hypopnea Index (AHI). Likewise, the ApneaLink and SOMNOscreen devices provide CSR information, and the SOMNOscreen, Noga System and ARES device calculate the AHI. This information may be used to assist physicians in the diagnosis of sleep related breathing disorders. The Morpheus Ox System is further indicated to display other information obtained from the connected photoplethysmograph system, consistent with information provided by the cleared predicates.
The use of Morpheus Ox System in cardiac patients exclusively to provide information to assist in diagnosis of sleep related breathing disorders, and especially in the detection of CSR and estimation of AHI, does not alter the intended diagnostic effect of the device, namely the provision of information that can be used to assist in diagnosis of such disorders.
Technological Characteristics
Like the cleared Noga System, the Morpheus Ox System is a software-only program that is used in conjunction with a cleared pulse oximeter device. Both devices process the raw signal data acquired by a pulse oximeter system in standard medical format, analyze the signals, obtain the study's analysis results, generate summary reports, and display the signals' data and reports on a personal computer, using a standard Internet Explorer Browser. The Morpheus Ox software program is based on the Noga software program with the changes required to support its intended use and indications for use from the analysis of a different set of signals. The core software components and architecture are substantially equivalent.
Performance Testing
Software verification and validation testing was conducted to evaluate the performance of the Morpheus Ox System and to verify that it performs according to its specifications described in the Software Requirements Specifications (SRS). In addition, a clinical study was conducted to validate the accuracy of the Morpheus Ox System against both a gold-standard PSG and predicate device.
3
Summary
Based on the performance testing results, including software verification and validation process and the analysis of the similarities and differences, the Morpheus Ox System is substantially equivalent to its predicates.
4
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/4/Picture/1 description: The image shows a logo for the Department of Health & Human Services USA. The logo features a stylized eagle with three curved lines representing its wings. The eagle is positioned to the right of the text, which is arranged in a circular pattern around the left side of the logo.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Deganit Barak-Shinar C/O Dr. John Smith Hogan Lovells US LLP 555 Thirteenth Street, NW Washington, DC 20004
AUG 31 2011
Re: K111314
Trade/Device Name: Morpheus Ox Automated Sleep Study Scoring and Data Management System Regulation Number: 21 CFR 868.2375 Regulation Name: Breathing Frequency Monitor Regulatory Class: II Product Code: MNR Dated: August 17, 2011 Received: August 17, 2011
. Dear Dr. Smith:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
5
Page 2 - Dr. Smith
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices /ucm115809 htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance,
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely vours.
Nh for
Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
INDICATIONS FOR USE
510(k) Number (if known): _ _ _ _ ____________________________________________________________________________________________________________________________________________
Device Name: Morpheus Ox Automated Sleep Study Scoring and Data Management System
Indications for Use:
The Morpheus Ox Automated Sleep Study Scoring and Data Management System is a computer program (software) intended for use as an aid in the detection of Cheyne-Stokes Respiration (CSR), and to estimate Apnea Hypopnea Index (AHI), in a Cardiac patient population that is suspected of having Sleep Disordered Breathing (SDB). The Morpheus Ox System is intended to be used for analysis, display, redisplay (retrieve), reports generation and networking of physiological data received from an oximeter device. It does not perform automatic classification of respiratory events as central or obstructive. This system is to be used under the supervision of a physician.
Morpheus Ox displays heart rate, saturation and photoplethysmograph signals, acquired from an oximeter device. Morpheus Ox may also display signals including: EtCO2, Respiratory impedance, Plethysmograph Derived Respiratory (PDR) calculated signal, Activity, ECG, EEG, P flow, C flow, EMG, EOG, Snore, Leg movement, Abdomen, Thorax, EPAP, IPAP.
| Prescription Use | √ |
|---|---|
| (Part 21 CFR 801 Subpart D) |
AND/OR
| Over-The-Counter Use | |
|---|---|
| (21 CFR 801 Subpart C) |
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
L. Schultheis
(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number: K 113
4-2
Page 1 of 1